Clinical Trial Update: A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery [Phase 4]

View source ↗

Summary

Phase 4 trial investigating sublingual misoprostol to reduce primary postpartum hemorrhage after vaginal delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: The University of Hong Kong | Conditions: Primary Postpartum Hemorrhage, Misoprostol | Phase 4 | Status: UNKNOWN